BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22983233)

  • 1. [Efficasy and safety of the use of risperidone (rispoluxe) in demented patients with psychotic and behavioural disorders].
    Bocharov AV; Kondakova VE; Tuleninov ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6):25-31. PubMed ID: 22983233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimizing atypical antipsychotic treatment strategies in the elderly.
    Katz IR
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S272-7. PubMed ID: 15541168
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis.
    Ellingrod VL; Schultz SK; Ekstam-Smith K; Kutscher E; Turvey C; Arndt S
    Pharmacotherapy; 2002 Jan; 22(1):1-5. PubMed ID: 11794418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living.
    Yoon JS; Kim JM; Lee H; Shin IS; Choi SK
    Hum Psychopharmacol; 2003 Dec; 18(8):627-33. PubMed ID: 14696022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone questioned as dementia first-line treatment.
    Saxe T
    Geriatrics; 2004 Feb; 59(2):11; author reply 11-2. PubMed ID: 14989589
    [No Abstract]   [Full Text] [Related]  

  • 8. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric outpatients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145(42):55. PubMed ID: 14655446
    [No Abstract]   [Full Text] [Related]  

  • 10. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients.
    Kissling W; Glue P; Medori R; Simpson S
    Hum Psychopharmacol; 2007 Dec; 22(8):505-13. PubMed ID: 17902187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risperidone in the treatment of psychotic, affective and behavioral symptoms associated to Alzheimer's disease].
    Barcia D; Giles E; Herraiz M; Moríñigo A; Roca M; Rodríguez A
    Actas Esp Psiquiatr; 1999; 27(3):185-90. PubMed ID: 10431061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrovascular events after treatment of dementia patients with risperidone.
    Wancata J
    Int Psychogeriatr; 2004 Dec; 16(4):493-5. PubMed ID: 15715366
    [No Abstract]   [Full Text] [Related]  

  • 15. Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update.
    DeVane CL; Mintzer J
    Psychopharmacol Bull; 2003; 37(4):116-32. PubMed ID: 15131522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of risperidone for the treatment of geriatric psychosis.
    Hwang JP; Yang CH; Yu HC; Chang JW; Cheng CY; Tsai SJ
    J Clin Psychopharmacol; 2001 Dec; 21(6):583-7. PubMed ID: 11763005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changeover to risperidone after treatment with conventional low potency neuroleptics in dementia patients. An observation study during usage].
    Stoppe G; Schreiner A; Schmitt AB
    Dtsch Med Wochenschr; 2006 Mar; 131(9):423-9. PubMed ID: 16493564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of risperidone therapy in elderly patients with chronic psychosis.
    Sajatovic M; Ramirez LF; Vernon L; Brescan D; Simon M; Jurjus G
    Int J Psychiatry Med; 1996; 26(3):309-17. PubMed ID: 8976471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching between clozapine and risperidone treatment.
    Gardner DM; Baldessarini RJ; Benzo J; Zarate CA; Tohen M
    Can J Psychiatry; 1997 May; 42(4):430-1. PubMed ID: 9161773
    [No Abstract]   [Full Text] [Related]  

  • 20. Risperidone long-acting injection in practice - more questions than answers?
    Taylor D
    Acta Psychiatr Scand; 2006 Jul; 114(1):1-2. PubMed ID: 16774654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.